Howe & Rusling’s PRA Health Sciences, Inc. PRAH Stock Holding History

Howe & Rusling’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-37	Closed	-$5K	–	1045
2020 Q4	$5K	Hold	37	–	–	﹤0.01%	644
2020 Q3	$4K	Buy	37 +1	+3%	+$102	﹤0.01%	625
2020 Q2	$4K	Buy	+36	New	+$3.35K	﹤0.01%	590
2019 Q4	–	Sell	-3,455	Closed	-$343K	–	899
2019 Q3	$343K	Hold	3,455	–	–	0.06%	153
2019 Q2	$343K	Buy	+3,455	New	+$330K	0.06%	148
2016 Q3	–	Sell	-86	Closed	-$4K	–	1157
2016 Q2	$4K	Buy	86 +4	+5%	+$184	﹤0.01%	713
2016 Q1	$4K	Hold	82	–	–	﹤0.01%	744
2015 Q4	$4K	Hold	82	–	–	﹤0.01%	704
2015 Q3	$3K	Hold	82	–	–	﹤0.01%	774
2015 Q2	$3K	Buy	+82	New	+$2.59K	﹤0.01%	812

Other funds holding PRAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Howe & Rusling's PRAH Position: Q1 2021 in Review

Howe & Rusling sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 37 shares — an estimated $5K sold.

Howe & Rusling first reported a position in PRAH in Q2 2015 and held it in 10 quarters. The position peaked at $343K in Q3 2019. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

Howe & Rusling reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
Howe & Rusling sold 37 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $5K.
Howe & Rusling first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 10 quarters.
Howe & Rusling's PRA Health Sciences, Inc. position peaked at $343K in Q3 2019.
324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Howe & Rusling's 13F filing for Q1 2021, filed 13 May 2021.